BRITTNY PATTERSON: Open Payments
NPI 1477319838 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $678 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Lundbeck LLC | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Corium, LLC | 1 | $8 |
Products named: VRAYLAR, INGREZZA, REXULTI, ARISTADA, CAPLYTA, INVEGA SUSTENNA, UZEDY, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
